Fisher & Paykel Healthcare Corp Ltd
FPH: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.% | LOCK|!Dwx | LOCK|KN^Ch<Gj |
Fisher & Paykel Healthcare Earnings: Better Than Expected on Currency Benefit and Operating Leverage
Fisher & Paykel Healthcare's interim 2026 underlying EBIT grew 27%, driven by 15% higher hospital product sales and operating leverage. It lifted full-year revenue and net profit after tax guidance, which, along with the strong result, is likely why shares rose 5%.
